Evaluation of novel bisbenzamidines as potential drug candidates for Pneumocystis carinii pneumonia.

被引：0
|
作者：
Cushion, MT
Walzer, PD
Vanden Eynde, JJ
Mayence, A
Huang, TL
机构：
[1] Univ Cincinnati, Dept Internal Med, Div Infect Dis, Cincinnati, OH 45267 USA
[2] Xavier Univ, Coll Pharm, Dept Basic & Pharmaceut Sci, New Orleans, LA 70125 USA
[3] Xavier Univ, Coll Pharm, Vet Affairs Med Ctr, Res Serv, New Orleans, LA 70125 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 227卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
068-MEDI
引用
收藏
页码：U18 / U18
页数：1
相关论文
共 50 条
  • [21] Increased dosage of infliximab is a potential cause of Pneumocystis carinii pneumonia
    Takuya Iwama
    Aki Sakatani
    Mikihiro Fujiya
    Kazuyuki Tanaka
    Shugo Fujibayashi
    Yoshiki Nomura
    Nobuhiro Ueno
    Shin Kashima
    Takuma Gotoh
    Junpei Sasajima
    Kentaro Moriichi
    Katsuya Ikuta
    Gut Pathogens, 8
  • [22] Antibody mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pneumocystis carinii pneumonia.
    Gigliotti, F
    Garvy, BA
    Harmsen, AG
    PEDIATRIC RESEARCH, 1996, 39 (04) : 1017 - 1017
  • [23] Immunohistochemical study of Pneumocystis carinii infection in pigs:: evaluation of Pneumocystis pneumonia and a retrospective investigation
    Kondo, H
    Hikita, M
    Ito, M
    Kadota, K
    VETERINARY RECORD, 2000, 147 (19) : 544 - 549
  • [24] Anti-pneumocystis carinii pneumonia (PCP) drug design and synthesis
    Zhang, J
    Delia, TJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U869 - U869
  • [25] New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia
    Kovacs, JA
    Gill, VJ
    Meshnick, S
    Masur, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19): : 2450 - 2460
  • [26] Favorable outcome after allogeneic BMT in patient with myelofibrosis and a previous episode of Pneumocystis carinii (PC) pneumonia.
    Vasta, S
    Milone, G
    Peluso, R
    Li Gioi, F
    Inghilterra, G
    Guido, G
    Fiandaca, T
    Manenti, G
    Giustolisi, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S234 - S234
  • [27] Peripheral CD4+T-lymphocyte counts in non-HIV Pneumocystis carinii pneumonia.
    Mansharamani, NG
    Balachandran, D
    Vernovsky, I
    Garland, R
    Koziel, H
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A227 - A227
  • [28] CYCLOSPORINE THERAPY AND REFRACTORY PNEUMOCYSTIS-CARINII PNEUMONIA - A POTENTIAL ASSOCIATION
    FRANSON, TR
    KAUFFMAN, HM
    ADAMS, MB
    LEMANN, J
    CABRERA, E
    HANACIK, L
    ARCHIVES OF SURGERY, 1987, 122 (09) : 1034 - 1035
  • [29] Highly active anti-pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds
    Cushion, MT
    Walzer, PD
    Collins, MS
    Rebholz, S
    Eynde, JJV
    Mayence, A
    Huang, TL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) : 4209 - 4216
  • [30] ATYPICAL PNEUMOCYSTIS-CARINII PNEUMONIA - THE POTENTIAL HAZARDS OF EMPIRIC TREATMENT
    PETERS, JW
    SATTLER, FR
    SOUTHERN MEDICAL JOURNAL, 1983, 76 (06) : 800 - 803
12345